Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection

Autor: Frost, Joe N., Tan, Tiong Kit, Abbas, Munawar, Wideman, Sarah K., Bonadonna, Michael, Stoffel, Nicole U., Wray, Katherine, Kronsteiner, Barbara, Smits, Gaby, Campagna, Dean R., Duarte, Tiago L., Lopes, José M., Shah, Akshay, Armitage, Andrew E., Arezes, João, Lim, Pei Jin, Preston, Alexandra E., Ahern, David, Teh, Megan, Naylor, Caitlin, Salio, Mariolina, Gileadi, Uzi, Andrews, Simon C., Dunachie, Susanna J., Zimmermann, Michael B., van der Klis, Fiona R.M., Cerundolo, Vincenzo, Bannard, Oliver, Draper, Simon J., Townsend, Alain R.M., Galy, Bruno, Fleming, Mark D., Lewis, Marie C., Drakesmith, Hal

Publikováno v: In Med 12 February 2021 2(2):164-179

Ancient genomic linkage couples metabolism with erythroid development.

Autor: Preston AE; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Frost JN; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Badat M; MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Teh M; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Armitage AE; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Norfo R; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Wideman SK; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Hanifi M; MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., White N; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Roy N; MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Ghesquiere B; Metabolomics Expertise Center, VIB Center for Cancer Biology, 3000 Leuven, Belgium.; Metabolomics Expertise Center, Department of Oncology, Katholieke Universiteit Leuven, 3000 Leuven, Belgium., Babbs C; MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Kassouf M; MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Davies J; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Hughes JR; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Beagrie R; Chromatin and Disease Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Higgs DR; MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK., Drakesmith H; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Sep 25. Date of Electronic Publication: 2023 Sep 25.